Apogee Therapeutics Eulerpool Ziņas

Apogee Therapeutics Eulerpool News

Apogee Therapeutics Akciju Ziņas

Apogee Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Apogee Therapeutics ziņas mēs apkopojam šeit.

• 18. septembris ·

  GuruFocus
  Fairmount Funds Management LLC Expands Stake in Viridian Therapeutics Inc
• 13. septembris ·

  GuruFocus
  Fairmount Funds Management LLC Acquires New Stake in ARCA biopharma Inc
• 12. septembris ·

  Yahoo
  Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
• 9. septembris ·

  Yahoo
  Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
• 7. septembris ·

  Yahoo
  Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
• 4. septembris ·

  Thefly.com
  Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
• 24. augusts ·

  Yahoo
  Insider Sale: CFO Jane Henderson Sells 6,000 Shares of Apogee Therapeutics Inc (APGE)
• 20. augusts ·

  SeekingAlpha
  Franklin Biotechnology Discovery Fund Q2 2024 Commentary
• 19. augusts ·

  Yahoo
  Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
• 19. augusts ·

  TipRanks
  Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial